Results 91 to 100 of about 5,472 (197)

Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension

Annals of Cardiac Anaesthesia, 2019
Introduction: Milrinone at inotropic doses requires the addition of a vasoconstrictive drug. We hypothesized that terlipressin use could selectively recover the systemic vascular hypotension induced by milrinone without increasing the pulmonary vascular ...
Mai Mohsen Abdelazziz, Hadil Magdi Abdelhamid   +1 more
doaj   +1 more source

Pediatric Sepsis: clinical Considerations [PDF]

, 2018
L
Balázs, Gergely, Dahlem, P., Elek, Norbert, Szima, Sándor   +3 more
core   +1 more source

Clinical implications of the hyperdynamic syndrome in cirrhosis. [PDF]

, 2014
The hyperdynamic syndrome is a late consequence of portal hypertension in cirrhosis. The principal hemodynamic manifestations of the hyperdynamic syndrome are high cardiac output, and increased heart rate and total blood volume, accompanied by reduced ...
CALVARUSO, Vincenza, CAMMA', Calogero, CRAXI, Antonio, INGRASSIA, Daniela, LICATA, Anna, MAZZOLA, Alessandra   +5 more
core   +1 more source

Гепаторенальний синдром в практиці сімейного лікаря (критерії діагнозу та лікування) [PDF]

, 2009
Під гепаторенальним синдромом (ГРС) розуміють функціональну олігуричну прогресуючу, але зворотню патологію нирок, що виникає при важких захворюваннях печінки з печінковою недостатністю, коли виключені інші чинники, що сприяють ураженню нирок.
Вовк, К.В., Ніколенко, Є.Я., Савченко, В.М., Сокруто, О.В.   +3 more
core  

Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study [PDF]

, 2008
Background Patients with advanced cirrhosis of the liver typically display circulatory disturbance. Haemodynamic management may be critical for avoiding and treating functional renal failure in such patients. This study investigated the effects of plasma
Andreas Umgelter, Katrin Wagner, Wolfgang Reindl, Nils Nurtsch, Wolfgang Huber, Roland M Schmid, RW Schrier, JH Henriksen, L Ruiz-del-Arbol, M Epstein, D Cheyron, R Moreau, P Sort, F Salerno, A Kumar, O Goedje, F Michard, A Zollinger, C Alessandria, PE Marik, R Raper, F Michard, EV Newman, P Meier, O Goedje, MS Goepfert, JH Henriksen, K Brinch, G Della Rocca, SG Sakka, JH Henriksen, R Fincke, S Møller, K Bendjelid, J Fernandez, K Lenz, R Ortega, M Thomas, X Monnet, B Lamia, S Møller, X Monnet   +41 more
core   +2 more sources

Self-expandable metal stents in the treatment of acute esophageal variceal bleeding [PDF]

, 2014
Acute variceal bleeding (AVB) is a life-threatening complication in patients with cirrhosis. Hemostatic therapy of AVB includes early administration of vasoactive drugs that should be combined with endoscopic therapy, preferably banding ligation. However,
Bosch i Genover, Jaume, Escorsell i Mañosa, M. Àngels   +1 more
core   +2 more sources

Prevention of acute kidney injury and protection of renal function in the intensive care unit : update 2017 [PDF]

, 2017
Background: Acute kidney injury (AKI) in the intensive care unit is associated with significant mortality and morbidity. Objectives: To determine and update previous recommendations for the prevention of AKI, specifically the role of fluids, diuretics ...
Druml, W, Forni, LG, Groeneveld, ABJ, Honore, PM, Hoste, Eric, Joannidis, M, Ostermann, M, Oudemans-van Straaten, HM, Schetz, Mathias   +8 more
core   +3 more sources

TERLIPRESSIN VERSUS NORADRENALINE FOR HEPATORENAL SYNDROME. Economic evaluation under the perspective of the Brazilian Public Health System

Arquivos de Gastroenterologia
Background - Terlipressin and noradrenaline are the best studied treatments for hepatorenal syndrome, and there is no evidence of superiority of one over the other regarding to efficacy.
Ângelo Zambam de MATTOS, Angelo Alves de MATTOS, Rodrigo Antonini RIBEIRO   +2 more
doaj   +1 more source

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.

PLoS ONE
The treatment of choice for hepatorenal syndrome-acute kidney injury (HRS-AKI) is vasoconstrictor therapy in combination with albumin, preferably norepinephrine or terlipressin as recommended by recent guidelines.
Jody C Olson, Ram M Subramanian
doaj   +1 more source

Terlipressin [PDF]

Reactions Weekly, 2020
openaire   +2 more sources